Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
Quick facts
Marketed products
- Active comparator: DRV/cb · Infectious Disease
DRV/c (darunavir boosted with cobicistat) is a protease inhibitor combined with a pharmacokinetic booster that blocks HIV protease to prevent viral replication. - Experimental: RAL QD
- Humalog Kwikpen · Diabetes
Humalog is a rapid-acting insulin analog that binds to insulin receptors to facilitate glucose uptake and utilization in cells. - Prednisone continuation · Immunology
Prednisone is a corticosteroid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors. - Prednisone withdrawal
- Toujeo SoloStar · Diabetes
Toujeo SoloStar is a long-acting basal insulin that binds to insulin receptors to lower blood glucose by promoting glucose uptake and storage in cells.
Phase 3 pipeline
- Metformin + Testosterone Undecanoate · Endocrinology / Metabolic Disease
Metformin improves insulin sensitivity and glucose metabolism while testosterone undecanoate restores androgen levels, together addressing metabolic dysfunction and hypogonadism.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: